Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial -
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Chemotherapy pre-treatment sensitizes AML cells to DNT-mediated... | Download Scientific Diagram
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
The “7+3” regimen in acute myeloid leukemia | Haematologica
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial - The
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
Chemotherapy dosing schedule. The schedule for ARA-C (200 mg/m 2 /d),... | Download Scientific Diagram
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
1930-R-MPV/high dose cytarabine overview | eviQ
Flowchart of regimen consisting of cladribine, cytarabine and etoposide... | Download Scientific Diagram
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
Genetic factors influencing cytarabine therapy | Pharmacogenomics
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas | Haematologica
JCM | Free Full-Text | Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
Chemotherapy protocol for primary CNS lymphoma | Download Table
High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+3 - ScienceDirect
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar
Core binding factor acute myelogenous leukemia-2021 treatment algorithm | Blood Cancer Journal
